-

AM Best to Host Briefing on Cyber Insurance Trends; Industry Panel to Discuss Top Risks and How to Mitigate Them

OLDWICK, N.J.--(BUSINESS WIRE)--A panel of AM Best analysts and industry experts will discuss trends in the cyber insurance segment in an online briefing scheduled for Thursday, July 25, 2024, at 10:00 a.m. EDT.

Topics during the Best’s Briefing, titled, “Cyber Insurance Market – Providing Dynamic Solutions for a Fast-Paced Risk,” will include current and prospective pricing conditions, growth prospects and the leading risks facing the market, as well as how participants are tackling risks through underwriting, risk modeling, reinsurance and ILS. AM Best recently assigned a stable market segment outlook to the global cyber insurance market, citing greater demand and potential for further market growth.

Miguel Canals, senior vice president, cyber treaty underwriter, Munich Re; Chris Mee, managing director, Aon; and Alex Tenenbaum, director of services, CyberCube, will join Christopher Graham, senior industry analyst, AM Best, on the panel. Sridhar Manyem, senior director, Industry Research and Analytics, AM Best, will moderate.

To register for the briefing, please visit the event and registration webpage.

AM Best also has released its annual review of the U.S. cyber insurance market. Issues explored in the Best’s Market Segment Report, include premium growth trends and key concerns such as systemic risk, risk aggregations and artificial intelligence.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2024 by AM Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

Contacts

Christopher Sharkey
Associate Director, Public Relations
+1 908 882 2310
christopher.sharkey@ambest.com

Al Slavin
Senior Public Relations Specialist
+1 908 882 2318
al.slavin@ambest.com

AM Best


Release Versions
Hashtags

Contacts

Christopher Sharkey
Associate Director, Public Relations
+1 908 882 2310
christopher.sharkey@ambest.com

Al Slavin
Senior Public Relations Specialist
+1 908 882 2318
al.slavin@ambest.com

Social Media Profiles
More News From AM Best

AM Best Affirms Credit Ratings of Halyk-Life, JSC

LONDON--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of B++ (Good) and the Long-Term Issuer Credit Rating of “bbb” (Good) of Halyk-Life, Life Insurance Subsidiary Company of the Halyk Bank of Kazakhstan, JSC (Halyk-Life) (Kazakhstan). The outlook of these Credit Ratings (ratings) is stable. The ratings reflect Halyk-Life’s balance sheet strength, which AM Best assesses as very strong, as well as its strong operating performance, limited business profile and marginal enter...

AM Best Affirms Credit Ratings of Euro Accident Livförsäkring AB

AMSTERDAM--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) of Euro Accident Livförsäkring AB (Euro Accident) (Sweden). The outlook of these Credit Ratings (ratings) is stable. The ultimate parent of Euro Accident is Impilo AB, a Swedish investment firm focused on Nordic healthcare investments. The ratings reflect Euro Accident’s balance sheet strength, which AM Best assesses as strong, as well as it...

AM Best Affirms Credit Ratings of AmTrust Assicurazioni S.p.A.

AMSTERDAM--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) of AmTrust Assicurazioni S.p.A. (AmTrust Assicurazioni) (Italy). The outlook of these Credit Ratings (ratings) is stable. The ratings reflect AmTrust Assicurazioni’s balance sheet strength, which AM Best assesses as very strong, as well as its adequate operating performance, limited business profile and appropriate enterprise risk management...
Back to Newsroom